Publication | Open Access
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
129
Citations
34
References
2015
Year
Tumor ImmunologyCancer ImmunosurveillanceAntagonistic Human FcγriibImmunologyTumor ImmunityAntibody ScreeningHumoral ImmunityAntibody EngineeringImmunotherapeuticsAnti-tumor ActivityImmunotherapyMedicineRadiation OncologyCancer ResearchAntibody Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1